Αποτελέσματα Αναζήτησης
1 Οκτ 2021 · D75.839 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM D75.839 became effective on October 1, 2024. This is the American ICD-10-CM version of D75.839 - other international versions of ICD-10 D75.839 may differ. Applicable To.
- 2025 ICD-10-CM Diagnosis Code D75.83: Thrombocytosis
ICD 10 code for Thrombocytosis. Get free rules, notes,...
- 2025 ICD-10-CM Diagnosis Code D75.83: Thrombocytosis
ICD 10 code for Thrombocytosis. Get free rules, notes, crosswalks, synonyms, history for ICD-10 code D75.83.
19 Αυγ 2022 · Thrombocytosis refers to an increased platelet count which, in this review, is >450,000/microL (>450 x 10 9 /L). This topic discusses our approach to the adult or child with unexplained thrombocytosis. Clinical manifestations and diagnosis of specific causes of thrombocytosis are discussed separately.
D75.89 is a billable diagnosis code used to specify a medical diagnosis of other specified diseases of blood and blood-forming organs. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025. Approximate Synonyms.
30 Δεκ 2022 · Thrombocytosis (throm-boe-sie-TOE-sis) is a disorder in which your body produces too many platelets. It's called reactive thrombocytosis or secondary thrombocytosis when the cause is an underlying condition, such as an infection.
D75.839 is a billable diagnosis code used to specify a medical diagnosis of thrombocytosis, unspecified. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.
15 Μαρ 2012 · Essential thrombocythemia is currently defined as a persistent thrombocythemic state (platelet count ≥ 450 × 10 9 /L) that is neither reactive nor associated with an otherwise defined myeloid malignancy (including polycythemia vera), primary myelofibrosis (including prefibrotic primary myelofibrosis), CML, and myelodysplastic syndromes. In ...
